+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Test Strips Market - Global Forecast to 2030- Product Image
Blood Glucose Test Strips Market - Global Forecast to 2030- Product Image
Sale

Blood Glucose Test Strips Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010976
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Test Strips Market grew from USD 6.37 billion in 2024 to USD 6.88 billion in 2025. It is expected to continue growing at a CAGR of 7.89%, reaching USD 10.06 billion by 2030.

Over the past decade, blood glucose test strips have evolved from basic colorimetric tools to highly sophisticated diagnostics that support personalized diabetes management. As diabetes prevalence rises worldwide, the demand for more accurate, user-friendly and data-driven monitoring solutions has never been greater. This report opens by examining the intersecting forces of patient needs, technological innovation and healthcare economics that have propelled test strips into the spotlight. It outlines how real-time glucose tracking and seamless data integration now form the backbone of modern care pathways, empowering individuals and clinicians to make informed therapeutic decisions. By framing the competitive landscape and identifying unmet clinical requirements, this introduction sets the stage for a deeper exploration of the market’s transformative shifts, policy influences and strategic imperatives.

Transformative Shifts Redefining Glucose Monitoring Solutions

In recent years, the blood glucose strip market has undergone several transformative shifts that are reshaping product design, distribution and patient engagement. First, the emergence of continuous glucose monitoring solutions has accelerated investment in personalized analytics and closed-loop insulin delivery. Second, the integration of mobile-connected strips and data-analytics platforms has turned discrete measurements into actionable insights, improving adherence and enabling remote care. Third, environmentally-friendly materials and budget-friendly alternatives are gaining traction among cost-conscious payers and patients. Fourth, novel reflectance photometry and non-enzyme-based sensors are challenging established enzyme-dependent formats by offering faster readings and extended shelf life. Finally, regulatory harmonization and value-based reimbursement models are incentivizing manufacturers to demonstrate real-world clinical outcomes. Together, these shifts are fueling a new era in which agility, digitalization and sustainability define leadership.

Cumulative Impact of United States Tariffs on the 2025 Supply Chain

United States tariffs slated for 2025 are poised to exert cumulative pressure on the supply chain for blood glucose test strips and related components. Import duties on key raw materials and finished goods may drive up production costs, compelling manufacturers to re-evaluate sourcing strategies and negotiate with alternate suppliers. To mitigate margin erosion, many producers are expected to relocate manufacturing to duty-exempt jurisdictions or absorb a portion of the tariff impact through leaner operations. At the same time, distributors and end-users may face higher acquisition prices, potentially slowing adoption among price-sensitive segments. The resulting shift in trade flows could reshape global partnerships, with Asia-based suppliers vying for new contracts. In this environment, agility in procurement, diversified manufacturing footprints and proactive policy engagement will be essential to sustain competitive advantage.

Key Segmentation Insights Driving Market Differentiation

Segmentation analysis reveals the multi-dimensional nature of demand and innovation within the test-strip market. Based on product type, the landscape spans continuous glucose monitoring strips-further divided into personal and professional CGM formats-as well as disposable, reusable and standard strips and integrated glucose monitoring systems. From a technology perspective, offerings include biosensor solutions that leverage electrochemical and optical strips, enzyme-based test strips differentiated by glucose dehydrogenase versus glucose oxidase technology, non-enzyme-based test strips and reflectance photometry tools. End-user classes range from hospitals and ambulatory surgical centers to clinics and home care settings. Consumer demographics play a vital role in shaping design features across age groups, from children to adults and the elderly, and gender-specific preferences among male and female users. Distribution channels stretch from hospital pharmacies and retail outlets to hypermarkets, supermarkets and online pharmacies. Usage frequency segments cover frequent, moderate and occasional users, while packaging variants include multi-pack and single-use options. Innovation-driven categories encompass budget-friendly strips, data-analytics supported formats, environmentally-friendly alternatives and mobile-connected products. Testing methods focus on capillary versus venous blood sampling, and pricing tiers span economy, mid-range and premium.

Regional Dynamics Shaping Growth Patterns Across Territories

Regional dynamics are defining divergent growth trajectories and strategic priorities. In the Americas, strong insurance coverage and high diabetes prevalence underpin steady demand for advanced continuous glucose monitoring solutions, while emerging players explore direct-to-consumer online pharmacy channels. Within Europe, Middle East and Africa, regulatory harmonization across the European Union coupled with government initiatives in the Middle East is fostering investment in data-driven strips and telemedicine integration, whereas African markets remain underserved but represent untapped potential. The Asia-Pacific region exhibits a dual trend: established economies such as Japan and South Korea focus on premium, mobile-connected strips and closed-loop systems, while fast-growing markets in China, India and Southeast Asia drive adoption of budget-friendly and multi-pack formats to address affordability and large patient populations.

Leading Players and Competitive Positioning in Glucose Strips

Competitive positioning is marked by a balance between global incumbents and agile innovators. Major diagnostics groups, including the maker of consumer-oriented glucose meters, leverage established manufacturing scale and extensive distribution networks. Meanwhile, specialized firms explore niche advantages: one developer focuses on next-generation non-enzyme-based sensors, another pursues environmentally-friendly materials, and a third integrates advanced data analytics into its strips. Leading players encompass Menarini Diagnostics s.r.l, AgaMatrix, Inc., B. Braun Medical Ltd, Bayer AG, BioSensors, Inc., F. Hoffmann-La Roche Ltd, GlucoRx Limited, i-SENS Inc, LifeScan, Inc., National Diagnostic Products Pty Ltd, Nipro Diagnostics UK Limited, PHC Holdings Corporation, Spirit Healthcare, TaiDoc Technology Corporation and Universal Biosensors Group. These companies compete on factors such as technological innovation, quality assurance, regulatory compliance, channel partnerships and global footprint, while smaller entrants differentiate through focused R&D and strategic licensing collaborations.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize several strategic actions to capture emerging opportunities. First, accelerate integration of data-driven features by forging partnerships with digital health platforms and telemedicine providers. Second, diversify sourcing and manufacturing footprints to mitigate tariff risks and ensure supply continuity. Third, invest in environmentally-friendly and budget-conscious product variants to address regulatory pressures and cost-sensitive segments. Fourth, expand direct-to-consumer and e-commerce channels to enhance patient access and adherence. Fifth, deepen engagement with payers and regulatory bodies to secure favorable reimbursement and support value-based care models. By executing these initiatives, companies can fortify resilience, differentiate offerings and drive sustainable growth.

Strategic Conclusion and Market Implications

The evolving blood glucose test strip market is characterized by accelerating technological convergence, shifting policy landscapes and heightened patient expectations. Companies that align product innovation with digital integration, environmental stewardship and flexible distribution will set the benchmark for value creation. Concurrently, proactive risk management around tariffs and supply-chain disruptions will separate the resilient from the vulnerable. By synthesizing the insights on segmentation, regional dynamics and competitive positioning, stakeholders can refine their strategies to address both established and emergent market demands. Ultimately, success will depend on an organization’s ability to pivot swiftly, forge strategic alliances and deliver demonstrable clinical and economic benefits.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Test Strips Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Continuous Glucose Monitoring (CGM) Strips
    • Personal CGM
    • Professional CGM
  • Disposable Strips
  • Glucose Monitoring Systems
  • Reusable Strips
  • Standard Strips
  • Biosensor Technology
    • Electrochemical Strips
    • Optical Strips
  • Enzyme-Based Test Strips
    • Glucose Dehydrogenase
    • Glucose Oxidase
  • Non-Enzyme-Based Test Strips
  • Reflectance Photometry
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings
  • Hospitals
  • Age Group
    • Adults
    • Children
    • Elderly
  • Gender
    • Female
    • Male
  • Hospital Pharmacies
  • Hypermarkets And Supermarkets
  • Online Pharmacies
  • Retail Pharmacies
  • Frequent Users
  • Moderate Users
  • Occasional Users
  • Multi-Pack
  • Single-Use Pack
  • Budget-Friendly Strips
  • Data Analytics Supported Strips
  • Environmentally-Friendly Strips
  • Mobile-Connected Strips
  • Capillary Blood Sampling
  • Venous Blood Sampling
  • Economy
  • Mid-Range
  • Premium

This research report categorizes the Blood Glucose Test Strips Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Blood Glucose Test Strips Market to delves into recent significant developments and analyze trends in each of the following companies:

  • A. Menarini Diagnostics s.r.l
  • AgaMatrix, Inc.
  • B. Braun Medical Ltd
  • Bayer AG
  • BioSensors, Inc.
  • F. Hoffmann-La Roche Ltd
  • GlucoRx Limited
  • i-SENS Inc
  • LifeScan, Inc.
  • National Diagnostic Products Pty Ltd
  • Nipro Diagnostics UK Limited
  • PHC Holdings Corporation
  • Spirit Healthcare
  • TaiDoc Technology Corporation
  • Universal Biosensors Group

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Glucose Test Strips Market, by Product Type
8.1. Introduction
8.2. Continuous Glucose Monitoring (CGM) Strips
8.2.1. Personal CGM
8.2.2. Professional CGM
8.3. Disposable Strips
8.4. Glucose Monitoring Systems
8.5. Reusable Strips
8.6. Standard Strips
9. Blood Glucose Test Strips Market, by Technology
9.1. Introduction
9.2. Biosensor Technology
9.2.1. Electrochemical Strips
9.2.2. Optical Strips
9.3. Enzyme-Based Test Strips
9.3.1. Glucose Dehydrogenase
9.3.2. Glucose Oxidase
9.4. Non-Enzyme-Based Test Strips
9.5. Reflectance Photometry
10. Blood Glucose Test Strips Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Home Care Settings
10.5. Hospitals
11. Blood Glucose Test Strips Market, by Consumer Demographics
11.1. Introduction
11.2. Age Group
11.2.1. Adults
11.2.2. Children
11.2.3. Elderly
11.3. Gender
11.3.1. Female
11.3.2. Male
12. Blood Glucose Test Strips Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Hypermarkets And Supermarkets
12.4. Online Pharmacies
12.5. Retail Pharmacies
13. Blood Glucose Test Strips Market, by Usage Frequency
13.1. Introduction
13.2. Frequent Users
13.3. Moderate Users
13.4. Occasional Users
14. Blood Glucose Test Strips Market, by Packaging
14.1. Introduction
14.2. Multi-Pack
14.3. Single-Use Pack
15. Blood Glucose Test Strips Market, by Innovations
15.1. Introduction
15.2. Budget-Friendly Strips
15.3. Data Analytics Supported Strips
15.4. Environmentally-Friendly Strips
15.5. Mobile-Connected Strips
16. Blood Glucose Test Strips Market, by Testing Method
16.1. Introduction
16.2. Capillary Blood Sampling
16.3. Venous Blood Sampling
17. Blood Glucose Test Strips Market, by Pricing
17.1. Introduction
17.2. Economy
17.3. Mid-Range
17.4. Premium
18. Americas Blood Glucose Test Strips Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Blood Glucose Test Strips Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Blood Glucose Test Strips Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. A. Menarini Diagnostics s.r.l
21.3.2. AgaMatrix, Inc.
21.3.3. B. Braun Medical Ltd
21.3.4. Bayer AG
21.3.5. BioSensors, Inc.
21.3.6. F. Hoffmann-La Roche Ltd
21.3.7. GlucoRx Limited
21.3.8. i-SENS Inc
21.3.9. LifeScan, Inc.
21.3.10. National Diagnostic Products Pty Ltd
21.3.11. Nipro Diagnostics UK Limited
21.3.12. PHC Holdings Corporation
21.3.13. Spirit Healthcare
21.3.14. TaiDoc Technology Corporation
21.3.15. Universal Biosensors Group
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. BLOOD GLUCOSE TEST STRIPS MARKET MULTI-CURRENCY
FIGURE 2. BLOOD GLUCOSE TEST STRIPS MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD GLUCOSE TEST STRIPS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2024 VS 2030 (%)
FIGURE 24. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2024 VS 2030 (%)
FIGURE 26. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD GLUCOSE TEST STRIPS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PERSONAL CGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PROFESSIONAL CGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISPOSABLE STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REUSABLE STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STANDARD STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ELECTROCHEMICAL STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OPTICAL STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GLUCOSE DEHYDROGENASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GLUCOSE OXIDASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY NON-ENZYME-BASED TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REFLECTANCE PHOTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY HYPERMARKETS AND SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY FREQUENT USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY MODERATE USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OCCASIONAL USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY MULTI-PACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY SINGLE-USE PACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BUDGET-FRIENDLY STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DATA ANALYTICS SUPPORTED STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENVIRONMENTALLY-FRIENDLY STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY MOBILE-CONNECTED STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CAPILLARY BLOOD SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY VENOUS BLOOD SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ECONOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY MID-RANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PREMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 111. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 113. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 116. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 118. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 120. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 122. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 123. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 124. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 125. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 188. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 190. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 193. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 195. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 197. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 199. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 200. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 201. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 202. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 203. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 205. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 208. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 210. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 212. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 214. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 215. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 216. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 217. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 233. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 235. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 238. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 240. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 241. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 242. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 244. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 245. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 246. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 247. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INNOVATIONS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRICING, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) STRIPS, 2018-2030 (USD MILLION)
TABLE 310. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 311. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY BIOSENSOR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYME-BASED TEST STRIPS, 2018-2030 (USD MILLION)
TABLE 313. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)

Companies Mentioned

  • A. Menarini Diagnostics s.r.l
  • AgaMatrix, Inc.
  • B. Braun Medical Ltd
  • Bayer AG
  • BioSensors, Inc.
  • F. Hoffmann-La Roche Ltd
  • GlucoRx Limited
  • i-SENS Inc
  • LifeScan, Inc.
  • National Diagnostic Products Pty Ltd
  • Nipro Diagnostics UK Limited
  • PHC Holdings Corporation
  • Spirit Healthcare
  • TaiDoc Technology Corporation
  • Universal Biosensors Group

Methodology

Loading
LOADING...

Related Topics

Related Reports

Blood Glucose Test Strips Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Glucose Test Strips Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Blood Glucose Test Strips Market Report by Type, Technology, Distribution Channel, End User, and Region 2025-2033 - Product Image

Blood Glucose Test Strips Market Report by Type, Technology, Distribution Channel, End User, and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
Blood Glucose Test Strip (BGTS) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Blood Glucose Test Strip (BGTS) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 91 Pages
  • Global
From
Blood Glucose Test Strips - Global Strategic Business Report - Product Image

Blood Glucose Test Strips - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Blood Glucose Test Strips Market - Forecasts from 2024 to 2029 - Product Image

Blood Glucose Test Strips Market - Forecasts from 2024 to 2029

  • Report
  • 124 Pages
  • Global
From

About the Blood Glucose Test Strip Market

The Blood Glucose Test Strip market is a segment of the Medical Devices industry. It is composed of products used to measure the amount of glucose in a person's blood. These test strips are used in conjunction with a glucometer, a device that reads the test strip and displays the glucose level. The test strips are typically disposable and are used to monitor and manage diabetes. The market is driven by the increasing prevalence of diabetes, as well as the need for accurate and reliable glucose monitoring. Additionally, technological advancements in test strip design have enabled more accurate readings and improved patient outcomes. Some companies in the Blood Glucose Test Strip market include Abbott Laboratories, Roche Diagnostics, LifeScan, Ascensia Diabetes Care, and B. Braun Melsungen AG. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.